Compare Definium Therapeutics Inc. Common Shares (DFTX) vs ProShares UltraPro QQQ ETF (TQQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs ProShares UltraPro QQQ ETF — how do they compare? Definium Therapeutics Inc. Common Shares trades at $37.05 (market cap $4.59B), while ProShares UltraPro QQQ ETF trades at $81.3 (market cap $38.74B). The key difference: ProShares UltraPro QQQ ETF is far larger — about 8.4× Definium Therapeutics Inc. Common Shares's market cap, and ProShares UltraPro QQQ ETF is trading nearer its 52-week high, Definium Therapeutics Inc. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and ProShares UltraPro QQQ ETF for 24 Days on average.
| DFTX | TQQQ | |
|---|---|---|
Market Cap | $4.59B | $38.74B |
Volume | 2,103,937 | 65,384,797 |
Sector | Health | Leveraged / Inverse |
52-Week High | $48.45 | $87.22 |
52-Week Low | $10.68 | $37.89 |
Typical Hold Time | 0 Days | 24 Days |
Enterprise Value | $3.55B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TQQQ trades at $81.28, down 2.78% on the day, with technical indicators showing a bullish bias despite recent selling pressure. The ETF maintains a strong position near its pivot point of $81, supported by positive moving average signals. Recent news highlights ongoing institutional interest alongside concerns about hidden costs and volatility risks inherent in leveraged ETF structures.
The outlook remains cautiously optimistic given the bullish technical setup, though investors face significant volatility risks amplified by the 3x leverage structure. Key opportunities include exposure to Nasdaq-100 growth, while risks center on expense ratios, financing costs, and potential market corrections that could magnify losses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About ProShares UltraPro QQQ ETF
TQQQ is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the Nasdaq-100 Index. It is one of the most liquid and actively traded instruments in the market, designed for sophisticated traders to amplify short-term bullish exposure to large-cap non-financial growth stocks, predominantly in the technology and communication sectors.
Read more on TQQQ →
